Genomic Determinants of De Novo Resistance to Immune Checkpoint Blockade in Mismatch Repair-Deficient Endometrial Cancer

JCO Precis Oncol. 2020:4:492-497. doi: 10.1200/po.20.00009. Epub 2020 May 8.

Authors

Doga C Gulhan¹, Elizabeth Garcia², Elizabeth K Lee³, Neal I Lindemann², Joyce F Liu³, Ursula A Matulonis³, Peter J Park¹, Panagiotis A Konstantinopoulos³

Affiliations

¹ Harvard Medical School, Boston, MA.
² Brigham and Women's Hospital, Boston, MA.
³ Dana-Farber Cancer Institute, Boston, MA.

No abstract available

Grants and funding